Cosomil, Inc is a startup based in Japan, most recent round Series A, 1 tracked investor.
Cosomil, Inc is a startup based in Japan. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Cosomil develops a high-precision diagnostic technology called single-molecule enzyme activity-based liquid biopsy to support early disease diagnosis and pharmaceutical development, focusing notably on early detection of pancreatic cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.